Price movement over the last 24 hours
Arthavest Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Arthavest Tbk trades at Rp2,600 (market cap 1.15T, 6.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Arthavest Tbk is far larger — about 7.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (2.51M versus 6.2K). Which is the better fit depends on your goals.
| ARTA | OBAT | |
|---|---|---|
Market Cap | 1.15T | 160.57B |
Volume | 6.2K | 2.51M |
Lot | 62 | 25.09K |
Turnover | 15.85M | 636.74M |
Average Price | 2,557.1 | 253.78 |
Value | 15.85M | 636.74M |
Indicative Equilibrium Price | 2,600 | 242 |
Indicative Equilibrium Volume | 2 | 146 |
Trailing returns across standard periods
Latest headlines on both assets
PT Arthavest Tbk (the Company) was established under the name of PT Artha Securities Prima based on Notarial Deed No. 489 dated June 29, 1990 of Beny Kristianto, S.H.
Read more on ARTA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →